Timothy Saxe, MD
Internal Medicine · Huntington, WVNPI 1174520282
Payments from drug & device makers
Across 685 payments — averaging $12.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- AbbVie$985
- AstraZeneca$765
- Novo Nordisk$690
- GSK$680
- Boehringer Ingelheim$653
- plus $4K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 90 | $1,071 |
| AbbVie(2 entities) | 119 | $985 |
| AstraZeneca | 39 | $765 |
| Novo Nordisk | 63 | $690 |
| GSK | 51 | $680 |
| Boehringer Ingelheim | 50 | $653 |
| Amarin Pharma, Inc. | 51 | $561 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 39 | $445 |
| Merck | 23 | $416 |
| Amgen | 21 | $403 |
| Johnson & Johnson | 23 | $347 |
| Teva Pharmaceuticals USA, Inc. | 19 | $263 |
| Lilly USA, LLC | 23 | $227 |
| Sanofi-aventis U.S. LLC | 13 | $193 |
| Esperion Therapeutics, Inc. | 10 | $159 |
| Avanir Pharmaceuticals, Inc. | 11 | $149 |
| Valeritas, Inc. | 2 | $139 |
| Indivior Inc. | 6 | $85 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $67 |
| Daiichi Sankyo Inc. | 4 | $63 |
| Biohaven Pharmaceuticals, Inc. | 4 | $60 |
| Novartis | 4 | $57 |
| Eisai Inc. | 3 | $41 |
| Mallinckrodt Enterprises LLC | 2 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $28 |
| Bayer | 2 | $27 |
| Nevro Corp. | 1 | $18 |
| Shionogi Inc | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
| MDD US Operations, LLC | 1 | $11 |
How this compares
$8,708 in reported general payments places this provider in the 90th percentile of 573 internal medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Huntington
- Mustafa AwiliHuntington$906K
- Bisher MustafaHuntington$28K
- Charles MeadowsHuntington$19K
- David PatickHuntington$18K
- Stephen SmithHuntington$10K
- Shawn CoffmanHuntington$10K
- Ward PaineMorgantown$5.1M
- William ChapmanCharleston$1.7M
- David PickeringParkersburg$694K
- Laura DavissonMorgantown$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.